Suppr超能文献

基质内皮细胞通过 TNF 相关因子 BAFF、APRIL 和 CD40L 与慢性淋巴细胞白血病细胞建立双向交流。

Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.

机构信息

Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.

出版信息

J Immunol. 2012 Jun 15;188(12):6071-83. doi: 10.4049/jimmunol.1102066. Epub 2012 May 16.

Abstract

Chronic lymphocytic leukemia (CLL) is a clonal B cell disorder of unknown origin. Accessory signals from the microenvironment are critical for the survival, expansion, and progression of malignant B cells. We found that the CLL stroma included microvascular endothelial cells (MVECs) expressing BAFF and APRIL, two TNF family members related to the T cell-associated B cell-stimulating molecule CD40L. Constitutive release of soluble BAFF and APRIL increased upon engagement of CD40 on MVECs by CD40L aberrantly expressed on CLL cells. In addition to enhancing MVEC expression of CD40, leukemic CD40L induced cleavases that elicited intracellular processing of pro-BAFF and pro-APRIL proteins in MVECs. The resulting soluble BAFF and APRIL proteins delivered survival, activation, Ig gene remodeling, and differentiation signals by stimulating CLL cells through TACI, BAFF-R, and BCMA receptors. BAFF and APRIL further amplified CLL cell survival by upregulating the expression of leukemic CD40L. Inhibition of TACI, BCMA, and BAFF-R expression on CLL cells; abrogation of CD40 expression in MVECs; or suppression of BAFF and APRIL cleavases in MVECs reduced the survival and diversification of malignant B cells. These data indicate that BAFF, APRIL, and CD40L form a CLL-enhancing bidirectional signaling network linking neoplastic B cells with the microvascular stroma.

摘要

慢性淋巴细胞白血病(CLL)是一种起源不明的克隆性 B 细胞疾病。微环境中的辅助信号对于恶性 B 细胞的存活、扩增和进展至关重要。我们发现 CLL 基质包括表达 BAFF 和 APRIL 的微血管内皮细胞(MVEC),这两种 TNF 家族成员与与 T 细胞相关的 B 细胞刺激分子 CD40L 有关。当 CLL 细胞异常表达的 CD40L 与 MVEC 上的 CD40 结合时,可溶性 BAFF 和 APRIL 的组成性释放增加。除了增强 MVEC 上的 CD40 表达外,白血病 CD40L 诱导的裂解酶在 MVEC 中引发前 BAFF 和前 APRIL 蛋白的细胞内加工。由此产生的可溶性 BAFF 和 APRIL 蛋白通过刺激 CLL 细胞上的 TACI、BAFF-R 和 BCMA 受体传递存活、激活、Ig 基因重排和分化信号。BAFF 和 APRIL 通过上调白血病 CD40L 的表达进一步增强 CLL 细胞的存活。抑制 CLL 细胞上的 TACI、BCMA 和 BAFF-R 表达;MVEC 中 CD40 表达的中断;或 MVEC 中 BAFF 和 APRIL 裂解酶的抑制减少了恶性 B 细胞的存活和多样化。这些数据表明,BAFF、APRIL 和 CD40L 形成了一个 CLL 增强的双向信号网络,将肿瘤 B 细胞与微血管基质联系起来。

相似文献

2
Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.
Blood. 2004 Jan 15;103(2):679-88. doi: 10.1182/blood-2003-02-0540. Epub 2003 Sep 22.
5
BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.
Leuk Res. 2009 Oct;33(10):1319-27. doi: 10.1016/j.leukres.2009.03.030. Epub 2009 Apr 23.
8
BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.
Blood. 2007 Jan 15;109(2):703-10. doi: 10.1182/blood-2006-06-027755. Epub 2006 Sep 14.
9
SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia.
Haematologica. 2017 Nov;102(11):1890-1900. doi: 10.3324/haematol.2017.170571. Epub 2017 Aug 24.
10
No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells.
PLoS One. 2013 Apr 19;8(4):e61350. doi: 10.1371/journal.pone.0061350. Print 2013.

引用本文的文献

1
An unappreciated cell survival-independent role for BAFF initiating chronic lymphocytic leukemia.
Front Immunol. 2024 Feb 26;15:1345515. doi: 10.3389/fimmu.2024.1345515. eCollection 2024.
3
Endothelial cells in tumor microenvironment: insights and perspectives.
Front Immunol. 2024 Feb 15;15:1367875. doi: 10.3389/fimmu.2024.1367875. eCollection 2024.
4
The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia.
Cancers (Basel). 2023 Oct 26;15(21):5160. doi: 10.3390/cancers15215160.
6
Macrophage-Based Therapeutic Strategies in Hematologic Malignancies.
Cancers (Basel). 2023 Jul 22;15(14):3722. doi: 10.3390/cancers15143722.
8
The BAFF-APRIL System in Cancer.
Cancers (Basel). 2023 Mar 16;15(6):1791. doi: 10.3390/cancers15061791.
9
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine.
Front Immunol. 2022 Dec 1;13:1050183. doi: 10.3389/fimmu.2022.1050183. eCollection 2022.
10
CD160 receptor in CLL: Current state and future avenues.
Front Immunol. 2022 Nov 7;13:1028013. doi: 10.3389/fimmu.2022.1028013. eCollection 2022.

本文引用的文献

2
Innate control of B cell responses.
Trends Immunol. 2011 May;32(5):202-11. doi: 10.1016/j.it.2011.02.004. Epub 2011 Mar 16.
3
Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses.
Eur J Immunol. 2011 Mar;41(3):787-97. doi: 10.1002/eji.201040591. Epub 2011 Feb 1.
4
Immunoglobulin responses at the mucosal interface.
Annu Rev Immunol. 2011;29:273-93. doi: 10.1146/annurev-immunol-031210-101317.
6
7
B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia.
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18956-60. doi: 10.1073/pnas.1013420107. Epub 2010 Oct 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验